NBP
NovaBridge Biosciences
1.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -2,238.3% | -521.9% | -2,893.3% | 28.1% | -1,105.5% | – | -1,624.1% | – | – | |
| 14.5% | 12.5% | 52.1% | 1.5% | 38.8% | – | 23.7% | – | – | |
| 62.5% | 6.5% | 1,223.0% | 32.0% | 691.4% | – | 228.7% | – | – | |
| 222.3% | 273.5% | 616.0% | -15.6% | 448.2% | – | -829.3% | – | – | |
| 180.4% | 26.8% | 40.8% | 0.5% | 34.0% | – | 3.7% | – | – | |
| -1,399.6% | 17.7% | 708.2% | -13.1% | -826.1% | – | -2,399.4% | – | – | |
| – | – | 17.6% | – | – | – | – | – | – | |
| – | – | – | -0.3% | 0.0% | – | -193.1% | – | – | |
| – | – | – | – | 0.0% | – | 219.9% | – | – | |
| 6,733.8% | 2,751.3% | 509.0% | 223.0% | 674.7% | – | -184.0% | – | – | |
| 3,094.7% | 2,358.1% | -1,625.5% | 231.1% | -1,403.2% | – | -3,379.1% | – | – | |
| -2,418.8% | -548.7% | -2,934.1% | 27.6% | -1,139.5% | – | -1,627.8% | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.